FI932114A - Maolspecifika erytrocyter och tromboerytrocyter - Google Patents

Maolspecifika erytrocyter och tromboerytrocyter Download PDF

Info

Publication number
FI932114A
FI932114A FI932114A FI932114A FI932114A FI 932114 A FI932114 A FI 932114A FI 932114 A FI932114 A FI 932114A FI 932114 A FI932114 A FI 932114A FI 932114 A FI932114 A FI 932114A
Authority
FI
Finland
Prior art keywords
tromboerytrocyter
maolspecifika
erytrocyter
och
och tromboerytrocyter
Prior art date
Application number
FI932114A
Other languages
English (en)
Other versions
FI932114A0 (fi
Inventor
Barry S Coller
Original Assignee
Univ New York State Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ New York State Res Found filed Critical Univ New York State Res Found
Publication of FI932114A0 publication Critical patent/FI932114A0/fi
Publication of FI932114A publication Critical patent/FI932114A/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • A61K35/18Erythrocytes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5063Compounds of unknown constitution, e.g. material from plants or animals
    • A61K9/5068Cell membranes or bacterial membranes enclosing drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745Blood coagulation or fibrinolysis factors
    • C07K14/75Fibrinogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Botany (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI932114A 1990-11-09 1993-05-10 Maolspecifika erytrocyter och tromboerytrocyter FI932114A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61116490A 1990-11-09 1990-11-09
PCT/US1991/008430 WO1992008804A1 (en) 1990-11-09 1991-11-12 Erythrocytes and thrombo-erythrocytes as target specific agents

Publications (2)

Publication Number Publication Date
FI932114A0 FI932114A0 (fi) 1993-05-10
FI932114A true FI932114A (fi) 1993-07-01

Family

ID=24447889

Family Applications (1)

Application Number Title Priority Date Filing Date
FI932114A FI932114A (fi) 1990-11-09 1993-05-10 Maolspecifika erytrocyter och tromboerytrocyter

Country Status (7)

Country Link
EP (1) EP0558645A4 (fi)
JP (1) JPH06504535A (fi)
KR (1) KR930702341A (fi)
AU (1) AU651643B2 (fi)
CA (1) CA2095925A1 (fi)
FI (1) FI932114A (fi)
WO (1) WO1992008804A1 (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6521594B1 (en) 1990-04-06 2003-02-18 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5672585A (en) * 1990-04-06 1997-09-30 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5780303A (en) * 1990-04-06 1998-07-14 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US6017877A (en) * 1990-04-06 2000-01-25 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
GB9705787D0 (en) 1997-03-20 1997-05-07 Thrombosis Res Inst Modified dendroaspins
CA2317640A1 (en) * 1998-01-06 1999-07-15 Trustees Of Boston University Decorated red blood cells
DE10038900A1 (de) * 2000-08-09 2002-03-07 Haemosys Gmbh Einfache Methode zum drug monitoring von GPIIb/IIIa-Rezeptor-Antagonisten
US7195919B2 (en) * 2003-12-19 2007-03-27 Beckman Coulter, Inc. Hematology controls for reticulocytes and nucleated red blood cells
DE102004054536A1 (de) * 2004-11-06 2006-05-11 Capsulution Nanoscience Ag Multimodal veränderte Zellen als zellulare Darreichungsformen für aktive Substanzen und als diagnostische Zellpartikel
WO2007083949A1 (en) * 2006-01-19 2007-07-26 Eyegene Inc. Pharmaceutical composition for treating vascular-related diseases comprising peptide
EP1849482A1 (en) * 2006-04-25 2007-10-31 Capsulution Nanoscience AG Multimodally altered cells as a form for administering active substances and as diagnostic particles
KR100824396B1 (ko) * 2006-10-10 2008-04-22 (주)케어젠 상피세포 성장인자의 활성을 가지는 펩타이드 및 그의 용도
CN101625267B (zh) * 2008-07-11 2011-07-20 财团法人工业技术研究院 热侦测***及其侦测方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4377567A (en) * 1978-10-02 1983-03-22 The Procter & Gamble Company Lipid membrane drug delivery
DE3218121A1 (de) * 1982-05-14 1983-11-17 Leskovar, Peter, Dr.-Ing., 8000 München Arzneimittel zur tumorbehandlung
US4792525A (en) * 1982-08-04 1988-12-20 La Jolla Cancer Research Foundation Tetrapeptide
US4988621A (en) * 1985-05-24 1991-01-29 La Jolla Cancer Research Foundation Peptides in cell detachment and aggregation
JPS62190129A (ja) * 1986-02-18 1987-08-20 Green Cross Corp:The 制癌剤含有マイクロキヤリアの製造方法
US5000960A (en) * 1987-03-13 1991-03-19 Micro-Pak, Inc. Protein coupling to lipid vesicles

Also Published As

Publication number Publication date
KR930702341A (ko) 1993-09-08
EP0558645A4 (en) 1994-07-06
JPH06504535A (ja) 1994-05-26
WO1992008804A1 (en) 1992-05-29
AU9058891A (en) 1992-06-11
CA2095925A1 (en) 1992-05-10
EP0558645A1 (en) 1993-09-08
AU651643B2 (en) 1994-07-28
FI932114A0 (fi) 1993-05-10

Similar Documents

Publication Publication Date Title
FI923983A (fi) Kymotrypsinlika proteaser och deras inhibitorer
FI932285A0 (fi) Skyddshjaelm och loestagbart ansiktsskydd
FI934078A0 (fi) Haorvaordskompositioner innehaollande formgivnings/konditionerings-medel och mjukgoeringsmedel
FI925427A (fi) Styrkrets och foerfarande foer transmissionsutgaong
FI925533A0 (fi) Tantal- eller niobbaserad perovskit och foerfarande foer framstaellning daerav
FI924747A (fi) Peg-imidat och proteinderivat daerav
FI925480A (fi) Vattenloeslig pentacyklisk triterpenkomposition och foerfarande foer framstaellning av densamma
FI912760A (fi) Skivfilter och filterelement foer skivfilter
FI88433C (fi) Anordning foer ingaongs- och utgaongsluft och luftkonditioneringsfoerfarande
FI922920A (fi) Separationsfoerfarande och anordning haerfoer
FI931628A (fi) Identifieringsanordning och foerfarande foer saekerhetssystem
FI921741A (fi) En katalyt och belaeggningskomposition innehaollande densamma
FI932114A (fi) Maolspecifika erytrocyter och tromboerytrocyter
FI934325A0 (fi) Insekticid komposition och insekticida enheter
FI934187A (fi) Icke-foervraengda polyetenskumstrukturer och framstaellningsfoerfarande
FI933359A (fi) Fodertillsatsaemne och foerfarande
FI924083A (fi) Spaenningsdeviationkompensator foer slaecktid foer vaexelriktare och omformare
FI923562A (fi) Vattenloesliga hartsbaserade belaeggningar och blaeck
FI923606A (fi) Automatisk omslagsavlaegsningsmaskin och foerfarande
FI931625A0 (fi) Kromaner och tiokromaner med retinoidlik aktivitet
FI924767A0 (fi) Alkyleringsfoerfarande foer isoalkan-olefiner och katalysatorer foer detsamma
FI925857A (fi) Nytt konserveringssystem och komposition aendamaolsenlig foer konservering
FI930002A (fi) Renings- och aotervinningsfoerfarande och anordning foer utfoerande av foerfarandet
FI925983A0 (fi) Maenniskans meg-csf-protein och foerfaranden
FI933321A0 (fi) Aotertillslutbar paose och behaollare

Legal Events

Date Code Title Description
FD Application lapsed